Machine-learned biomarker identifies those at high risk for liver cancer
Medical Xpress
February 18, 2026
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a score that predicts the risk of liver cancer. Published in the journal Proceedings of the National Academy of Sciences, the study establishes that the protein MYCN drives liver tumorigenesis, specifically of the type of tumors found in the deadliest subtype of liver cancer.
Verticals
healthmedical
Originally published on Medical Xpress on 2/18/2026